Heparin and endothelial cell growth factor modulate collagen and proteoglycan production in human smooth muscle cells
- 1 August 1989
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 163 (1), 84-92
- https://doi.org/10.1016/0006-291x(89)92102-5
Abstract
No abstract availableThis publication has 35 references indexed in Scilit:
- Heparin potentiates the action of acidic fibroblast growth factor by prolonging its biological half‐lifeJournal of Cellular Physiology, 1989
- Effects of heparin on vascularization of artificial skin grafts in ratsExperimental and Molecular Pathology, 1988
- Regulation of Vascular Smooth Muscle Cell Growth by Heparin and Heparan SulfatesSeminars in Thrombosis and Hemostasis, 1987
- Effect of heparin on synthesis of short chain collagen by chondrocytes and smooth muscle cells.The Journal of cell biology, 1987
- Heparin protects basic and acidic FGF from inactivationJournal of Cellular Physiology, 1986
- Heparin potentiation of 3T3‐adipocyte stimulated angiogenesis: Mechanisms of action on endothelial cellsJournal of Cellular Physiology, 1986
- Human adult endothelial cell growth in cultureJournal of Vascular Surgery, 1984
- Human Endothelial Cells: Use of Heparin in Cloning and Long-Term Serial CultivationScience, 1983
- Cultured endothelial cells produce heparinlike inhibitor of smooth muscle cell growthThe Journal of cell biology, 1981
- Inhibition of rat arterial smooth muscle cell proliferation by heparin. II. In vitro studies.Circulation Research, 1980